Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
Iannone, Florenzo, Courvoisier, Delphine S., Gottenberg, Jacques Eric, Hernandez, Maria Victoria, Lie, Elisabeth, Canhão, Helena, Pavelka, Karel, Hetland, Merete Lund, Turesson, Carl, Mariette, XavierТом:
36
Мова:
english
Журнал:
Clinical Rheumatology
DOI:
10.1007/s10067-016-3505-5
Date:
April, 2017
Файл:
PDF, 548 KB
english, 2017
File converter
Більше результатів пошуку
More benefits 
